Report of Foreign Issuer (6-k)
September 25 2017 - 4:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
Form 6-K
__________________
Report
of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For
the Month of September 2017
Commission
File Number
001-33042
Rosetta Genomics Ltd.
(Translation of registrant’s name into English)
10 Plaut Street, Science Park
Rehovot 76706, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Rosetta Genomics Ltd.
On September 25, 2017 Rosetta Genomics
Ltd. (“
Rosetta
” or the “
Company
”) held an Extraordinary General Meeting of Shareholders
(the “
Extraordinary Meeting
”). The proxy statement for the Extraordinary Meeting (the “
Proxy
Statement
”) was filed by the Company with the Securities and Exchange Commission as Exhibit 99.1 to its Report on
Form 6-K on August 14, 2017, and is incorporated herein by reference. Both of the proposals set forth in the Proxy Statement
and put before the shareholders were approved at the Extraordinary Meeting.
Signatures
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
ROSETTA GENOMICS LTD.
|
|
|
Date:September 25, 2017
|
By:
|
/s/ Ron Kalfus
|
|
|
Ron Kalfus
Chief Financial Officer
|
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rosetta Genomics (CE) (USOTC:ROSGQ)
Historical Stock Chart
From Sep 2023 to Sep 2024